The pathogenesis of PAH is also associated with mutations in components of the BMP pathway, including bone morphogenetic protein receptor 2 (BMPR2), BMP9, ACVRL1, ENG, or SMAD9 (175–177), among others. Here, BMPR2 is linked to pulmonary arterial hypertension.